Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Castagna

Showing results (391-400 of 467) with videos related to

Pageof 47
Sort By:
Panminerva Medica|February 4, 2022
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumoniaStefano Franchini, Francesca Mette, Giovanni Landoni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapyAndrea Antinori, Dora Larussa, Antonella Cingolani, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 18, 2026
Implementation of HIV Pre-exposure Prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE Cohort SurveySilvia Nozza, Thomas Masoero, Alessandro Tavelli, et al.
AIDS (London, England)|May 25, 2021
Prevalence and outcomes of pregnancies in women with HIV over a 20-year periodJustyna D Kowalska, Annegret Pelchen-Matthews, Lene Ryom, et al.
Antiviral Therapy|September 13, 2006
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysisMassimo Puoti, Alessandro Cozzi-Lepri, Giuseppe Paraninfo, et al.
Open Forum Infectious Diseases|October 31, 2025
Use of Preventive Measures for Cardiovascular Disease in People With HIVNadine Jaschinski, Bastian Neesgaard, Ferdinand Wit, et al.
The Patient|May 30, 2020
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral SuppressionAndrea Antinori, Maria V Cossu, Barbara Menzaghi, et al.
The Patient|April 9, 2020
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral SuppressionAndrea Antinori, Maria V Cossu, Barbara Menzaghi, et al.
Antimicrobial Resistance and Infection Control|August 29, 2022
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centresAgnese Comelli, Camilla Genovese, Andrea Lombardi, et al.
Eclinicalmedicine|October 6, 2025
Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre studyErich Tusch, Lene Ryom, Christian Hoffmann, et al.
Pageof 47

Showing results (391-400 of 467) with videos related to

Sort By:
Pageof 47
Panminerva Medica|February 4, 2022
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumoniaStefano Franchini, Francesca Mette, Giovanni Landoni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 4, 2004
Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapyAndrea Antinori, Dora Larussa, Antonella Cingolani, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 18, 2026
Implementation of HIV Pre-exposure Prophylaxis (PrEP) in Italy (2023-2024): Results from the PrIDE Cohort SurveySilvia Nozza, Thomas Masoero, Alessandro Tavelli, et al.
AIDS (London, England)|May 25, 2021
Prevalence and outcomes of pregnancies in women with HIV over a 20-year periodJustyna D Kowalska, Annegret Pelchen-Matthews, Lene Ryom, et al.
Antiviral Therapy|September 13, 2006
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysisMassimo Puoti, Alessandro Cozzi-Lepri, Giuseppe Paraninfo, et al.
Open Forum Infectious Diseases|October 31, 2025
Use of Preventive Measures for Cardiovascular Disease in People With HIVNadine Jaschinski, Bastian Neesgaard, Ferdinand Wit, et al.
The Patient|May 30, 2020
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral SuppressionAndrea Antinori, Maria V Cossu, Barbara Menzaghi, et al.
The Patient|April 9, 2020
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral SuppressionAndrea Antinori, Maria V Cossu, Barbara Menzaghi, et al.
Antimicrobial Resistance and Infection Control|August 29, 2022
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centresAgnese Comelli, Camilla Genovese, Andrea Lombardi, et al.
Eclinicalmedicine|October 6, 2025
Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre studyErich Tusch, Lene Ryom, Christian Hoffmann, et al.
Pageof 47